Skip to content

Effect of NMBA on Surgical Conditions in THR

Effect of Neuromuscular Blockade on Surgical Conditions and Patient Reported Comfort Scores in Total Hip Replacement Arthroplasty

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03369782
Enrollment
0
Registered
2017-12-12
Start date
2017-12-15
Completion date
2018-05-31
Last updated
2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Surgery

Keywords

Muscle Tension, Skeletal Muscle Relaxants, Arthroplasties, Hip Replacement, Rocuronium, sugammadex

Brief summary

During Total hip replacement arthroplasty (THA), the hip joint first must be luxated in order to have access to the joints. A lot of force and torque must be carried out on the joint to perform this manipulation. This is both difficult for the surgeon and may cause additional tissue damage and postoperative pain. After placement of the prosthesis and reduction of the joint, the tension of the hip joint must be evaluated by the surgeon to ascertain the adequacy of the prosthesis. During luxation, minimal muscle tension would be ideal, while after reduction of the joint, normal muscle tension is desired to permit assessment of the mechanics of the hip joint. The aim of the study is to investigate whether deep neuromuscular block, combined with a reversal before mechanics assessment improves surgical conditions, surgical time, and postoperative patient comfort.

Detailed description

2X20 patients are randomised: Rocuronium-group (R-group) and Placebo-group (P-group). All patients receive standardised multimodal intravenous analgesia. After standardised induction of anasthesia and patient positioning, the patient is administered either placebo or rocuronium 0.9 mg/kg, followed by continuous infusion of either placebo or rocuronium 0.4 mg/kg/h. 1 minute before reduction of the hip joint, the patient is administered either sugammadex (R-group) or placebo (P-group) for full reversal of the neuromuscular block. During the surgery, time points are recorded for: incision, start luxation of the joint, start reduction of the joint, start skin closure. The surgeon is blinded for patient allocation. At three moments (after luxation, just before reduction of the joint, and after assessment of joint mechanics), the surgeon is asked to appraise the surgical conditions on an analogue scale. Postoperative analgesic consumption and pain scores are recorded. VAS scores for knee pain and hip pain are assessed before surgery, at the moment of discharge from the post-anesthesia care unit (=D0), the morning after surgery (=D1), at D2, and at D7.

Interventions

DRUGRocuronium

rocuronium is administered in bolus and continuous infusion

DRUGSugammadex

Sugammadex is administered just before reduction of the joint

DRUGPlacebo

Placebo is administered as alternative to rocuronium in a bolus and in a syringe pump. Placebo is administered as alternative to sugammadex

Sponsors

Algemeen Ziekenhuis Maria Middelares
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

The syringes are prepared by the research assistant who was not involved in patient management. The anesthetist and surgeon are blinded for patient allocation.

Intervention model description

Group A receives rocuronium, followed by sugammadex. Group B receives placebo

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* signed informed consent * eligible for primary THA * BMI \<35

Exclusion criteria

* neurological or psychiatric disorders * intolerance or allergy against investigational drugs or any of the drugs used in the standardized analgetics scheme (acetaminophen, diclofenac, ketamine, clonidine, lidocaine)

Design outcomes

Primary

MeasureTime frameDescription
Surgical conditions during luxation on a four-grade numeric scaleduring surgery, during luxation of the jointExcellent - good but not optimal - poor but acceptable - unacceptable

Secondary

MeasureTime frameDescription
Patient reported pain scores on a VAS score (0-100 ; 0=no pain , 100=worst pain)day 0-1-2-7 (day 0 = day of surgery)Patient reported pain scores in knee and hip after surgery at day 0-1-2-7
surgery timeduring surgerytime (in minutes) of surgery between incision and reduction, and between reduction and skin closure
Surgical conditions during reduction of the joint on a four-grade numeric scaleduring surgery, during reduction of the jointExcellent - good but not optimal - poor but acceptable - unacceptable
Surgical conditions for assessment of joint kinetics on a four-grade numeric scaleduring surgery, after reduction of the jointExcellent - good but not optimal - poor but acceptable - unacceptable

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026